EHP Funds’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLN
SL
EHP Funds's SLN Position: Q4 2025 in Review
EHP Funds sold out of Silence Therapeutics (SLN) in Q4 2025, closing a stake of 10,673 shares — an estimated $55.4K sold.
EHP Funds first reported a position in SLN in Q3 2025 and held it in 1 quarter. The position peaked at $55.4K in Q3 2025. 58 funds tracked by Wall St. Rank hold SLN as of Q4 2025.
- EHP Funds reported no remaining Silence Therapeutics position as of Q4 2025 after selling out during the quarter.
- EHP Funds sold 10,673 Silence Therapeutics shares in Q4 2025, an estimated $55.4K.
- EHP Funds first reported a position in Silence Therapeutics in Q3 2025 and held it in 1 quarter.
- EHP Funds's Silence Therapeutics position peaked at $55.4K in Q3 2025.
- 58 funds tracked by Wall St. Rank held Silence Therapeutics as of Q4 2025.
Based on EHP Funds's 13F filing for Q4 2025, filed 12 Feb 2026.